INR 3.7 Interpretation: Therapeutic Range Context and Clinical Action
An INR of 3.7 is above the standard therapeutic range (2.0–3.0) for most indications (atrial fibrillation, venous thromboembolism). However, target ranges vary:
- Mechanical mitral valve: 2.5–3.5 (some guidelines 3.0–4.0).
- Mechanical aortic valve with risk factors: 2.5–3.5.
Clinical Decision
- If on warfarin for standard indication: INR 3.7 warrants dose reduction or brief hold per protocol; repeat INR in 1–2 days.
- If target is 2.5–3.5: 3.7 is slightly high; minor adjustment may suffice.
- Bleeding risk: Assess for bruising, hematuria, melena, headache.
Never self-adjust warfarin. Contact the anticoagulation clinic or prescribing clinician for specific instructions.
Blood Disorders - Related Articles
- Blood Donation After Mononucleosis: Eligibility, Waiting Period, and Guidelines
- Infant Jaundice: Causes, Treatment & When to Seek Help
- Understanding White Blood Cell Counts: What They Mean for Your Health
- Potassium Chloride & Coumadin: Understanding Interactions & Effects
- Why Proteins Stay in Blood Vessels: The Size‑Selective Endothelial Barrier
- Managing Menstruation with Thrombocytopenia: A Comprehensive Guide
- Balancing Your pH: How Alkaline Foods Can Help
